Canada Canadian researchers concerned over continued spike in Covid-related cannabis and alcohol sales Cannabis sales have been 25% higher than estimated revenue if the pandemic didn't happen Natalia Buendia CalvilloNovember 5, 2021
Cannabis Consuming cannabis while on psychedelics makes the experience stronger, researchers say Cannabis and 'classical' psychedelics could act on similar receptors Natalia Buendia CalvilloNovember 4, 2021
Legalization Biden administration has options to legalize weed: congressional report Support for legalization remains high, a new poll shows, with more than two-thirds of Americans in favour Kathryn TindaleNovember 4, 2021
Business Canopy expands Deep Space brand A citrus soda and two gummy flavours, all with 10mg of THC, will be available to Canadians Nick LabaNovember 3, 2021
News New York won’t issue weed licences until 2023: regulator The state's cannabis law allows for sales to start in 2022, but weed stores won't be selling until mid-2023 Kathryn TindaleNovember 2, 2021
Business Sales spikes and other Halloween cannabis data trends with BDSA Whether dressing up for a night on the town, or curling up for a scary movie at home, many will supplement their celebrations with... Nick LabaOctober 29, 2021
Business Aurora partners with Valens to make minty seasonal products THC-infused mints and cranberry sauce vapes will be hitting shelves in select provinces this November Natalia Buendia CalvilloOctober 28, 2021
Business First medical cannabis flower hits New York shelves, Curaleaf says The state's cannabis control board announced legislative changes to increase patient access at a meeting Oct. 5 Nick LabaOctober 27, 2021
Business Metro Vancouver pot producers concerned over ‘ill-considered’ draft emission rules The proposed regulations are based on 'flawed' calculations, and would cause months-long shutdowns to change infrastructure, growers say Nick LabaOctober 25, 2021
International UK Prime Minister to consider reducing legal barriers to psilocybin research Conservative MP and drug policy reform chair Crispin Blunt suggests reclassifying the substance to a less severe category of the country's drug law Natalia Buendia CalvilloOctober 25, 2021